Development of a human liver microphysiological co-culture system for higher throughput chemical safety assessment.

3D co-culture HepaRG animal alternatives in vitro testing liver metabolism toxicity testing

Journal

Toxicological sciences : an official journal of the Society of Toxicology
ISSN: 1096-0929
Titre abrégé: Toxicol Sci
Pays: United States
ID NLM: 9805461

Informations de publication

Date de publication:
09 Feb 2024
Historique:
medline: 10 2 2024
pubmed: 10 2 2024
entrez: 9 2 2024
Statut: aheadofprint

Résumé

Chemicals in the systemic circulation can undergo hepatic xenobiotic metabolism, generate metabolites and exhibit altered toxicity compared to their parent compounds. This paper describes a two-chamber liver-organ co-culture model in a higher-throughput 96-well format for the determination of toxicity on target tissues in the presence of physiologically relevant human liver metabolism. This two-chamber system is a hydrogel formed within each well consisting of a central well (target tissue) and an outer ring-shaped trough (human liver tissue). The target tissue chamber can be configured to accommodate a three-dimensional (3D) spheroid-shaped microtissue, or a two-dimensional (2D) cell mono-layer. Culture medium and compounds freely diffuse between the two chambers. Human differentiated HepaRGTM liver cells are used to form the 3D human liver microtissues, which displayed robust protein expression of liver biomarkers (albumin, asialoglycoprotein receptor, Phase I cytochrome P450 (CYP3A4) enzyme, multidrug resistance-associated protein 2 transporter, and glycogen), and exhibited Phase I/II enzyme activities over the course of 17 days. Histological and ultrastructural analyses confirmed that the HepaRG microtissues presented a differentiated hepatocyte phenotype, including abundant mitochondria, endoplasmic reticulum and bile canaliculi. Liver microtissue zonation characteristics could be easily modulated by maturation in different media supplements. Furthermore, our proof-of-concept study demonstrated the efficacy of this co-culture model in evaluating testosterone-mediated androgen receptor responses in the presence of human liver metabolism. This liver-organ co-culture system provides a practical, higher-throughput testing platform for metabolism-dependent bioactivity assessment of drugs/chemicals, to better recapitulate the biological effects and potential toxicity of human exposures.

Identifiants

pubmed: 38335931
pii: 7604532
doi: 10.1093/toxsci/kfae018
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Blanche C Ip (BC)

Department of Pathology and Laboratory Medicine, Brown University, Providence, RI, USA.
Center for Alternatives to Animals in Testing, Brown University, Providence, RI, USA.

Samantha J Madnick (SJ)

Department of Pathology and Laboratory Medicine, Brown University, Providence, RI, USA.
Center for Alternatives to Animals in Testing, Brown University, Providence, RI, USA.

Sophia Zheng (S)

Department of Pathology and Laboratory Medicine, Brown University, Providence, RI, USA.

Tessa C A van Tongeren (TCA)

Division of Toxicology, Wageningen University and Research, Wageningen, NL, 6700 EA.

Susan J Hall (SJ)

Department of Pathology and Laboratory Medicine, Brown University, Providence, RI, USA.

Hui Li (H)

Department of Pathology and Laboratory Medicine, Brown University, Providence, RI, USA.

Suzanne Martin (S)

Unilever Safety and Environmental Assurance Centre, Sharnbrook, United Kingdom.

Sandrine Spriggs (S)

Unilever Safety and Environmental Assurance Centre, Sharnbrook, United Kingdom.

Paul Carmichael (P)

Unilever Safety and Environmental Assurance Centre, Sharnbrook, United Kingdom.

Wei Chen (W)

Corteva, Inc, Indianapolis, IN, USA.

David Ames (D)

Corteva, Inc, Indianapolis, IN, USA.

Lori A Breitweiser (LA)

Corteva, Inc, Indianapolis, IN, USA.

Heather E Pence (HE)

Corteva, Inc, Indianapolis, IN, USA.

Andrew J Bowling (AJ)

Corteva, Inc, Indianapolis, IN, USA.

Kamin J Johnson (KJ)

Corteva, Inc, Indianapolis, IN, USA.

Richard Cubberley (R)

Unilever Safety and Environmental Assurance Centre, Sharnbrook, United Kingdom.

Jeffrey R Morgan (JR)

Department of Pathology and Laboratory Medicine, Brown University, Providence, RI, USA.
Center for Alternatives to Animals in Testing, Brown University, Providence, RI, USA.

Kim Boekelheide (K)

Department of Pathology and Laboratory Medicine, Brown University, Providence, RI, USA.
Center for Alternatives to Animals in Testing, Brown University, Providence, RI, USA.

Classifications MeSH